Paxlovid associated with decreased hospitalization rate among adults with COVID-19 - United States, April-September 2022

Am J Transplant. 2023 Jan;23(1):150-155. doi: 10.1016/j.ajt.2022.12.004. Epub 2023 Jan 11.

Affiliations

¹ Coronavirus and Other Respiratory Viruses Division (proposed), National Center for Immunization and Respiratory Diseases, CDC, Verona, Wisconsin. Electronic address: bgn3@cdc.gov.
² Epic Research, Epic Systems Corporation, Verona, Wisconsin.
³ Coronavirus and Other Respiratory Viruses Division (proposed), National Center for Immunization and Respiratory Diseases, CDC, Verona, Wisconsin.

No abstract available

MeSH terms

Adult
COVID-19* / epidemiology
Hospitalization
Humans
United States / epidemiology

Substances

nirmatrelvir and ritonavir drug combination